Atlas Logo
PREVENT Dementia Programme (PREVENT)
PREVENT Dementia Programme logo
BACK
Sample details

PREVENT aims to examine risk factors for dementia. The study recruited adults aged 40 to 59 who were not diagnosed with dementia or had a known problem with magnetic resonance imaging (MRI) scans. Participants were recruited from across the United Kingdom and the Republic of Ireland to attend baseline testing in Edinburgh, Oxford, Cambridge, London, and Dublin. This resulted in a baseline cohort of 700 participants, with a mean age of 51.17 years and a predominance of female participants (61.9%).

Study design
Cohort, Cohort - research programme

Number of participants at first data collection

700 (participants)

Age at first data collection

40 - 59 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Middle-aged people
Dataset details
Loading map...

Countries

England, Ireland, Northern Ireland, Scotland, United Kingdom of Great Britain and Northern Ireland

Year of first data collection

2014

Primary Institutions

Imperial College London (Imperial, ICL)

Trinity College Dublin

University of Cambridge

University of Edinburgh (University o Edinburgh, Oilthigh Dhùn Èideann)

University of Oxford

Links

preventdementia.co.uk/

neurodegenerationresearch.eu/cohort/prevent-research-programme/

doi.org/10.3109/09540261.2013.869195

Funders

Alzheimer's Association

Alzheimer's Society

National Institute of Health and Medical Research (Institut national de la santé et de la recherche médicale, INSERM)

Ongoing?
Yes

Data types collected

neuroImagingData
mentalHealthData
qualitativeData
Quantitative data collection
  • Activity log (e.g. food, sleep, exercise)
  • Audio or visual recordings (e.g. of child behaviour, facial expressions)
  • Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
  • Interview – face-to-face
  • Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
  • Self-report questionnaire – unspecified
  • Wearable devices
Qualitative data collection
  • Interviews or focus groups
Neuroimaging data collection
  • Arterial Spin Labelling (ASL)
  • Diffusion Tensor Imaging (DTI)
  • Functional magnetic resonance imaging (fMRI)
  • Magnetic Resonance Imaging (MRI)
  • Magnetic Resonance Spectroscopy (MRS)
Linked or secondary data
  • None
Features

Engagement

  • Patients, service users, lived experience involvement
  • Participant or community advisory groups
  • Community engagement
  • Keywords

    Alzheimer's disease (AD)
    Biological samples/biospecimens
    Cognition
    Cognitive ageing and decline
    Cognitive assessments
    Dementia
    Genetic predisposition
    Neuroimaging
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis